Evidence map›Paper›PMID 41390687›Full record

ArticleScientific reports2025

Synthesis of 2'-fucosyllactose using multi-enzyme cascade with cofactor regeneration.

Chenqi Cao, Yi Bai, Mengxin Zhang, Shahin Shah Khan, Yu Ji, Luo Liu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenqi CaoState Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Yi BaiBeijing Eastern Biotech Co., Ltd., No.2 Rongjing Dong Street, Beijing Economic and Technological Development Zone, Beijing, China.
Mengxin ZhangState Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Shahin Shah KhanState Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Yu JiState Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. 2023500088@mail.buct.edu.cn.
Luo LiuState Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. liuluo@mail.buct.edu.cn.

Funding

National Natural Science Foundation of China 22378015
6 · The paper itself

Abstract

2'-Fucosyllactose (2'-FL) is a major human milk oligosaccharide with nutritional and medicinal benefits, widely used in infant formula and nutraceuticals. Now most studies focus on the synthesis of 2'-FL in vivo starting from glucose and glycerol. Here, we designed the first in vitro multi-enzyme cascade system for the de novo synthesis of 2'-FL using mannose and lactose as substrates. Central to this pathway is an engineered polyphosphate-dependent glucomannokinase (PPGMK), which enables efficient phosphorylation of mannose to G6P and thereby establishes mannose as an effective entry point for the de novo synthetic route. To enhance the production of 2'-FL, the cascade system was optimized, and apart from α-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (gmd) was determined as a crucial rate-limiting enzyme for the de novo synthesis of 2'-FL. Additionally, an efficient GTP regeneration system was achieved, which converted GDP to GTP using polyphosphate kinase 2, resulting in a 2.94-fold improvement in 2'-FL production. Finally, under optimized conditions incorporating the cofactor regeneration system, 13.18 mM 2'-FL was synthesized through a one-pot enzymatic reaction using 20 mM mannose and lactose as substrates. The engineered system demonstrated exceptional cofactor efficiency, requiring only 2 mM each of the essential cofactor NADPH and GTP representing a 6.6-fold reduction in cofactor consumption. Overall, this study establishes a novel de novo enzymatic route for 2'-FL and provides new insights for both pathway construction and enzyme engineering in oligosaccharide production.

Indexed as

TrisaccharidesFucosyltransferasesGuanosine TriphosphateHumansHydro-LyasesLactoseMannosePhosphotransferases (Alcohol Group Acceptor)2'-fucosyllactoseFucosyltransferasesGDPmannose 4,6-dehydrataseGuanosine TriphosphateHydro-LyasesLactoseMannosePhosphotransferases (Alcohol Group Acceptor)Trisaccharides2′-FucosyllactoseGTP regenerationHuman milk oligosaccharidesMulti-enzyme cascadeα-1,2-fucosyltransferase

Identifiers

PMID41390687
PMCPMC12820362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.